July 27, 2016 6:59 AM ET


Company Overview of Novartis Oncology

Company Overview

Novartis Oncology engages in the discovery and development of therapies and medicines for cancer. It focuses on the research platforms spanning discoveries in signal transduction inhibition, cytotoxic agents, antiangiogenesis, cell cyle/apoptosis, iron chelation, metastases, and hormone therapy. The company’s products include EXJADE, a drug indicated for the treatment of chronic iron overload due to frequent blood transfusions; Femara letrozole tablets indicated for the treatment of breast cancer in postmenopausal women; Glivec, a cancer treatment indicated for adult and pediatric patients with diagnosed Ph+ chronic myeloid leukemia; and Sandostatin LAR octreotide/IM injection for the treatm...

One Health Plaza

East Hanover, NJ 07936 1080

United States



Key Executives for Novartis Oncology

Global Head of Oncology Development and Executive Vice President
Vice President and Global Head of NIBR Oncology Research
Compensation as of Fiscal Year 2016.

Novartis Oncology Key Developments

Novartis Oncology - Special Call

Novartis Oncology - Special Call

Novartis Oncology Announces Sales Results for the First Half of 2015

Novartis Oncology announced sales results for the first half of 2015. For the period, sales grew 30%.

Novartis Oncology Presents at BIO-Europe 2014, Nov-03-2014 02:45 PM

Novartis Oncology Presents at BIO-Europe 2014, Nov-03-2014 02:45 PM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Anne Altmeyer, VP, Business Development and Licensing.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novartis Oncology, please visit www.novartisoncology.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.